Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Immediately following birth, the mouth has a substantial microflora living in symbiosis with a healthy host. , Molecular methods of 16S DNA amplification reveal a tremendously diverse bacterial environment, largely uncharacterized.
Caries is the most prevalent and consequential oral disease globally. In health, Streptococcus , Peptostreptococcus , and Veillonella species and diphtheroids account for more than 80% of the total recoverable flora of the oral cavity. Quantitative studies indicate that anaerobes outnumber facultative bacteria 8-fold. Facultative gram-negative bacilli are uncommon in the healthy child but may become prominent in seriously ill patients. Certain sites tend to adhere certain bacteria. For example, Streptococcus salivarius and Veillonella species have a predilection for the tongue and buccal mucosa and predominate before eruption of teeth. In contrast, Streptococcus sanguinis, Streptococcus mutans, and Actinomyces viscosus preferentially colonize the tooth surface while Fusobacterium , Prevotella, and Porphyromonas species and anaerobic spirochetes are concentrated in the gingival crevices.
In the United States, caries are the most common chronic disease of childhood and are 5 times more common than asthma. Caries of primary teeth commonly are referred to as caries of early childhood. Plaque-related bacteria colonize the tooth surface and produce a weak acid during their carbohydrate metabolism. Acid production lowers local pH and results in demineralization of the tooth with efflux of calcium, phosphorus, and carbonate. Tooth colonization with cariogenic bacteria is a key factor for development of caries. Bacterial 16S sequence analysis has shown association of S. mutans, S. salivarius, Streptococcus sobrinus , and Streptococcus parasanguinis with early stages of caries, and Veillonella species were predictive of future caries among children without history of caries. Lactobacilli are strongly associated with more advanced stages of caries. With progression of caries severity there is loss of healthy microbial community diversity. The major reservoir from which infants acquire cariogenic bacteria is from their primary care giver, usually the mother. Caries can affect any part of the tooth. In children, coronal caries typically have been found in the pits and fissures of the occlusal surfaces of molars and premolars. Food retention occurs less frequently at interproximal sites and the gingival margins except in infants who fall asleep drinking a bottle of milk or juice. In early childhood the disease develops over smooth surfaces. Treatment consists of restoration of the affected tooth augmented by preventive methods such as fluoride treatments, flossing, tooth brushing, meticulous removal of the biofilm, placement of sealants, and avoidance of sugary snacks and drinks. Maternal oral health education has had mixed impact on childhood caries.
Pericoronitis is an acute localized infection associated with operculum of the gum overlying partially erupted teeth or impacted wisdom teeth. The third molars (wisdom teeth) often are affected especially when their eruption is hindered by lack of space. The tissue around the tooth becomes red, edematous, and tender to touch, but the underlying bone usually is not involved. The patient reports continuous pain that ranges from dull to throbbing to intense, often radiating to the mouth, ear, throat, or floor of the mouth. Other symptoms can include swelling of the cheek, trismus, dysphagia, and foul breath smell. Systemic manifestations can include fever, chills, and submandibular, submental, or cervical lymphadenopathy. Treatment consists of gentle débridement, irrigation under the operculum, and a systemic antibiotic effective against mouth flora, along with incision and drainage if infection spreads into soft tissue.
Pulpal infection most frequently results from caries. Demineralization and destruction of the enamel is followed by invasion of the pulp to produce localized or generalized pulpitis . In early stages of infection ( reversible pulpitis) patients typically complain of tooth sensitivity to percussion and thermal changes, especially cold drinks. Pain stops abruptly when the stimulus is withdrawn. The ongoing inflammation and built-up pressure lead to pulp necrosis described as irreversible pulpitis. Complications of pulpitis include spread of infection to the adjacent periodontal ligaments and invasion of the alveolar bone condition called periapical abscess . Serious complications of periapical infections are rare. Among 75 cases of pulpitis, 16S rDNA sequencing revealed Lactobacillus genus as the most abundant bacteria causing reversible and irreversible pulpitis. However, in some cases infection spreads, causing abscesses in the submaxillary triangle or in the parapharyngeal or submasseteric space. In the maxilla, periapical infection can manifest in the soft tissues of the face. Infection also can extend to the infratemporal space including the sinuses and from there to the central nervous system, causing subdural empyema, brain abscess, or meningitis.
The most common organisms isolated from infected pulp include aerobic, facultative anaerobic organisms (i.e., S . salivarius , other alpha-hemolytic streptococci, nonhemolytic streptococci) and anaerobic streptococci, anaerobic gram-negative bacilli, Actinomyces spp., Propionibacterium spp., Veillonella spp., and others. Treatment consists of elimination of infected pulp (root canal treatment) or extraction of the tooth. Cochrane literature review found no evidence to support antibiotic use for treatment of pulpitis alone. There was no difference in pain perception or analgesic use among 40 patients with irreversible pulpitis randomly assigned to penicillin or placebo arm. Antibiotic therapy is indicated if drainage cannot be performed or the infection has spread to surrounding soft tissues. Penicillin usually is adequate; amoxicillin-clavulanate or clindamycin are effective against β-lactamase producing anaerobes.
Periodontitis is inflammation that extends deep into the tissues and causes loss of supporting connective tissue (periodontium) and alveolar bone. Severe periodontitis can result in loosening of teeth, impaired mastication, and even tooth loss. Bacterial species reproducibly associated with disease include Porphyromonas gingivalis, Tannerella forsythia, Aggregatibacter (formerly Actinobacillus ) actinomycetemcomitans , and Treponema denticola . In addition, a recent meta-analysis suggested association between Helicobacter pylori gastric infection and periodontal disease. Histologically, nonprogressive inflammatory foci tend to be composed predominantly of T lymphocytes and macrophages, suggesting that the cell-mediated response can control disease. Destructive lesions are dominated by B lymphocytes and plasma cells, suggesting that humoral immunity, although documented by elevated immunoglobulin G (IgG) levels against anaerobic organisms, is not always effective. ,
Juvenile (aggressive) periodontitis is a particularly destructive form of periodontitis seen in adolescents. Its localized form is characterized by rapid bone loss affecting the first molar and incisor teeth. The generalized form is rapidly progressive, affecting other teeth. Plaque is minimal, and specific defects in neutrophil chemotaxis and phagocytosis were demonstrated among 75% of patients. DNA probes and primers have revealed anaerobic organisms such as A . actinomycetemcomitans, P . gingivalis, Prevotella intermedia, T . denticola, and T . forsythia . Treatment consists of systemic antibiotics. Narrow-spectrum antibiotics such as penicillin, amoxicillin, cephalexin, and macrolides are not effective against increasing number of β-lactamase–producing anaerobes. Antibiotics that include β-lactamase inhibitor (i.e., clavulanate sulbactam) or clindamycin offer excellent coverage against the majority of aerobic and anaerobic oral pathogens. The decision whether to use narrow- or broader-spectrum antibiotic should be individualized.
Gingivitis is the most common periodontal disease during childhood, with peak incidence around adolescence. Inflammation is initiated by local irritation and bacterial invasion. Bleeding of the gums after eating or brushing and fetor oris can be early signs of gingivitis. There usually is no pain. Treatment consists of plaque removal and good oral hygiene. Differentiating features of oral infections and other conditions encountered frequently are shown in Tables 25.1 and 25.2 .
Agent | Acquisition | Usual Intraoral Site | Oral Manifestations |
---|---|---|---|
herpes Simplex Virus (HSV) Type 1 and 2 | |||
Primary gingivostomatitis | Saliva; direct contact with active lesions (oral, perioral, genital) | Anterior gingiva and mucosa, hard palate, tongue, lips | Vesicles, ulcers covered with yellowish exudates; gingival edema/erythema |
Herpes labialis | Saliva; direct contact with active lesions (oral, perioral, genital) | Lips | Vesicles, ulcers, and crusting |
Recurrent intraoral herpes | HSV reactivation | Gingiva, hard palate | Vesicles, ulcers |
Erythema multiforme | HSV reactivation | Buccal and labial mucosa, tongue, lips | Erythematous macules, vesicles, ulcers |
Varicella-Zoster Virus (VZV) | |||
Chickenpox | Saliva, direct contact with active lesions | Hard and soft palate, buccal mucosa, tongue, lips | Vesicles, ulcers |
Zoster | VZV reactivation | Palate, lips, tongue, buccal mucosa, gingiva | Unilateral vesicles, ulcers, bone necrosis, tooth exfoliation; pain along trigeminal nerve |
Epstein-Barr Virus (EBV) | |||
Infectious mononucleosis | Saliva | Hard and soft palate, gingiva | Lymphadenopathy, palatal petechiae, gingival necrosis, ulcers, edema of uvula |
Oral hairy leukoplakia | Established EBV infection | Lateral borders of the tongue | Vertical white, hyperkeratotic lesions |
Burkitt lymphoma | Not known | Maxilla, molar-premolar area | Tumors; loosening and displacement of teeth |
Nasopharyngeal carcinoma | Not known | Nasopharynx | Keratinizing squamous carcinoma; nonkeratinizing squamous carcinoma; undifferentiated carcinoma |
Cytomegalovirus | Congenital; breastfeeding; saliva | Teeth | Enamel hypoplasia, dental attrition, discoloration |
Human herpesvirus 8 | Possibly sexual transmission | Hard and soft palate | Kaposi sarcoma |
Coxsackieviruses | |||
Hand-foot-mouth disease | Saliva | Buccal and labial mucosa, tongue | Vesicles, ulcers |
Herpangina | Saliva | Soft palate | Vesicles, ulcers |
Human Papillomaviruses | |||
Condyloma acuminata | Direct contact with lesions | Tongue, gingiva, labial mucosa, palate | Soft, broad-based papules with a pebble-like surface |
Focal epithelial hyperplasia (Heck disease) | Direct contact with lesions; self-inoculation | Alveolar mucosa, lips | Soft, flat, nonpedunculated papules, usually with a pebble-like surface |
Squamous cell papilloma | Transformation chronic infection | Uvula, hard and soft palate, tongue, frenulum, lips, buccal mucosa, gingival | Soft, pedunculated, exophytic papules with cauliflower-like surface |
Verruca vulgaris | Direct contact with lesions, self-inoculation | Lips, tongue, labial mucosa, gingiva | Firm, broad-based elevated papules with cauliflower-like surface |
MOLLUSCUM CONTAGIOSUM | Direct contact with lesion | Lips | Waxy, dome-shaped papules |
MEASLES | Saliva, respiratory droplets | Buccal and labial mucosa; teeth | Bluish-white macules surrounded by erythema (Koplik spots); pitted enamel |
MUMPS | Saliva, respiratory droplets | Salivary glands | Swelling of salivary glands; erythema and edema of Wharton and Stensen duct openings; oral dryness |
RUBELLA | Saliva, respiratory droplets | Hard and soft palate | Petechiae; small dark-red papules (Forchheimer sign) |
HEPATITIS C VIRUS | Blood, sexual transmission | Buccal mucosa | Lichen planus |
SARS-CoV-2 | Saliva, respiratory droplets | Tongue, buccal mucosa, gingiva | Ulcers |
a Modified from Glick M, Siegel MA. Viral and fungal infections of the oral cavity in immunocompetent patients. Infect Dis Clin North Am . 1999:13;817–831.
Cause | Lesion | Site | Disease Course/Comment |
---|---|---|---|
Bacteria | |||
Scarlet fever ( Streptococcus pyogenes ) | Strawberry tongue | Tongue | Reddened edematous papillae project through white coating; coating peels off to leave red glistening tongue with prominent papillae |
Punctiform and petechial lesions | Palate | Intraoral erythema; uvula and free margin of soft palate red and edematous; lips uninvolved | |
Toxic shock syndrome ( Staphylococcus aureus ) | Intraoral erythema, edema, and desquamation | Lips, all intraoral mucous membranes | Can progress to painful desquamation |
Treponema pallidum | Painless ulcer with rolled edges | Anywhere on oral mucous membranes | Primary chancre heals over 5–10 days; followed by systemic manifestations if untreated |
Mouth flora gingivitis | Edema, thickening, erythema, and easy bleeding; usually painless | Gingiva and interdental papillae | Subgingival plaque always present; common in children, particularly during puberty |
Acute necrotizing ulcerative gingivitis (ANUG) | Pseudomembranes (necrosis of papillae) | Gingiva | Necrosis of interdental papillae results in marginated, punched-out, eroded appearance; grey necrotic pseudomembranes; fusiform bacilli and spirochetes consistently found |
Cystic gingival lesions | Red, cystic lesion, 4–10 mm | Gingival ridge | Infants <10 mo with pneumococcal bacteremia |
Glossitis | Swollen, red, painful | Tongue | S. pyogenes, Staphylococcus aureus, Haemophilus influenzae b |
Uvulitis | Red, edematous | Uvula | S. pyogenes, H. influenzae b; can cause respiratory compromise |
Fungus | |||
Candida species | Pseudomembranes of creamy white plaques on erythematous mucosa | Tongue, gingiva, buccal mucosa; rarely, pharynx, larynx, esophagus; cheilitis | Lesions can be painless, can burn, or can feel sore or dry |
Histoplasma capsulatum | Ulcers | Oropharynx | Occurs with subacute or chronic disseminated disease |
Unknown | |||
Kawasaki disease | Strawberry tongue; mucosal erythema; erythema, cracking peeling, bleeding lips | Tongue, oropharynx, lips | Mucosal erythema present in all but atypical forms |
Recurrent oral ulcerations (aphthous stomatitis) | Shallow, circular painful ulcer <5 mm on erythematous base with pseudomembrane | Nonkeratinized movable labial and buccal mucosa; tongue and floor of mouth | Healing occurs after 4 days; common (incidence 20%); recurrences 12 times/year; etiology unknown; symptomatic therapy |
Deep ulcers of >5 mm diameter; painful | All areas of oral cavity | Lasts 6 wk–3 mo; heals with scarring (Sutton scarring aphthae) | |
Small cluster of vesicles; extremely painful; no erythematous border | Tip and lateral margins of tongue | Herpetiform ulcers with no relationship to HSV | |
PFAPA syndrome | Small ulcers | Oral mucosa | Syndrome of recurrent fever, aphthous stomatitis, pharyngitis, and cervical adenitis; affects children <5 yr; recurrence every 2–9 wk |
Gangrenous stomatitis (noma) | Focal, destructive lesions | Gingiva and deeper structures | Rare, acute, fulminating in severely debilitated and malnourished children; spirochetes and other anaerobic bacteria may be involved |
Cyclic neutropenia and agranulocytosis | Small ulcers | Oral mucosa | |
Drug- or radiation-induced stomatitis | Ulcers and pseudomembrane formation; painful | Nonkeratinized labial and buccal mucosae soft palate; floor of mouth; ventral and lateral tongue surfaces | Microbiologic diagnosis important to rule out viral reactivation or bacterial superinfection |
Behçet syndrome | Ulcers | Oral mucosa | Multisystem disease that can involve many mucous membranes |
Stevens-Johnson syndrome | Macules, papules, vesicles, bullae | Buccal mucosa and vermilion border of the lips; relative sparing of gingivae | Erythema multiforme exudativum; 25% of cases confined to oral mucosa; lesions appear in crops; complete healing 4–6 wk; can cause recurrent stomatitis and labiitis |
Inflammatory bowel disease | Ulcers (aphthous-like) | Oral mucosa | Manifestation of multisystem disease |
HSV gingivostomatitis is the most recognized viral infection of the oral cavity. Primary infection with HSV-1 occurs throughout childhood, most commonly between the ages of 6 months and 5 years, and during adolescence and results in seropositivity in up to 90% of adults. , Up to 90% of children with primary HSV infections are asymptomatic. After primary infection, HSV remains dormant in the trigeminal ganglion and reactivates after stressful stimuli (i.e., cold, trauma, sunlight, intercurrent illness). Recrudescent disease has been estimated to occur in up to 40% of seropositive individuals. HSV infection is ubiquitous and acquired from symptomatic and asymptomatic people with primary or recurrent infection. Infections with HSV-1 usually result from direct contact with infected oral secretions. The incubation period for HSV infection beyond the neonatal period is 2 days to 2 weeks. In primary infection, vesicles appear on the first day of illness in 85% of symptomatic children and can persist for 7–18 days. Primary symptomatic infections are accompanied by fever, lymphadenopathy, malaise, pharyngitis, and anorexia. Gingiva are red, swollen, and bleeding. Small vesicles surrounded by red halo on the gingiva and anterior lingual and buccal mucosa rapidly rupture and coalesce giving rise to ulcerations. HSV gingivostomatitis is painful, and children commonly refuse to swallow, resulting in drooling. Differential diagnosis includes coxsackievirus infection (herpangina), erythema multiforme, pemphigus vulgaris, acute necrotizing ulcerative gingivitis (ANUG), and most commonly, aphthous stomatitis.
Complications of HSV gingivostomatitis include dehydration, herpetic whitlow or herpetic keratitis from autoinoculation, and secondary bacteremia with oral flora. , Recurrent HSV orolabial lesions occurs in one-third of individuals with prior HSV infection. Reactivation lesions typically are found around the gingiva, the hard palate, and vermilion border of the lip (“cold sore”). A prodrome of tingling, burning, and itching occurs 12–36 hours prior to the eruption of the vesicles. Viral shedding persisted for a mean of 7 days (range 2–12 days) among 36 untreated immunocompetent children in one study.
Treatment of HSV gingivostomatitis usually is palliative, with hydration and pain control. Topical application of diphenhydramine, simethicone (Maalox), and bismuth subsalicylate (Kaopectate) and viscous lidocaine frequently are prescribed; however, their usefulness and benefit have been questioned. Systemic analgesics (i.e., ibuprofen, paracetamol, acetaminophen) should be strongly considered to ease pain and improve intake and hydration.
A randomized, double-blind treatment trial in children using oral acyclovir during early stages reduced the duration of symptoms, improved healing, and reduced infectivity. A systematic review showed weak evidence that oral acyclovir offered treatment benefit. In general, most experts would treat patients (with oral acyclovir or valacyclovir) who come to attention early (within 96 hours of the onset of symptoms) or who have severe disease. Valacyclovir offers benefit of better bioavailability and less frequent dosing regimen compared with acyclovir. Chronic suppressive therapy can be used to reduce recurrences, such as in patients with facial, periorbital, or ocular lesions or very frequent episodes. Among healthy subjects, combination of early topical acyclovir 5% plus hydrocortisone 1% cream (ME-609) was more effective in reducing progression to ulcerative HSV lip lesions and reduced the size of the lesions compared with topical acyclovir alone or placebo.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here